*Actinobacillus pleuropneumoniae* is a Gram-negative bacterium and the etiologic agent of porcine pleuropneumonia, which causes serious economic losses to the pig-rearing industry \[[@r6]\]. To date, 15 serotypes are recognized, mainly on the basis of the antigenic diversity of capsular polysaccharides in the organisms \[[@r3], [@r19], [@r21], [@r22]\]. Since virulence differs among serotypes \[[@r6]\] and vaccines for *A. pleuropneumoniae* are serotype-specific \[[@r20], [@r25]\], serotyping is important and should be widely performed in veterinary diagnostic laboratories. However, only a few laboratories can prepare a full set of serotype-specific antisera for serotyping. Furthermore, cross-reactions are often observed among different serotypes, such as between serotypes 1, 9 and 11; serotypes 4 and 7; serotypes 3, 6, 8 and 15; this prevents the accurate and rapid typing of field strains \[[@r5],[@r6],[@r7]\].

Prevalent serotypes differ from country to country \[[@r5]\]. For example, the predominant serotypes are serotypes 1 and 5 in North America \[[@r5], [@r6]\], serotype 2 in most of Europe \[[@r5], [@r6]\], serotype 15 in Australia \[[@r3], [@r5], [@r6]\] and serotypes 2, 1 and 5 in Japan \[[@r5], [@r13]\]. Serotypes 1, 2, 5, 9 and 11 have been generally found to be more virulent than other serotypes \[[@r6]\]. However, approximately 15% of fattening pigs in a herd died due to acute pleuropneumonia caused by serotype 15 \[[@r14]\], indicating that serotype 15, unlike serotypes 3 and 12, should not be considered as low pathogenic \[[@r6]\]. The development of reliable serotyping tests and vaccines for serotype 15 would be important, because isolation cases of serotype 15 have recently increased in Japan \[[@r13]\] and North America \[[@r7]\], because cross-reactions are often observed among serotypes 3, 6, 8 and 15 \[[@r5], [@r6]\] and because no commercial vaccine is fully effective against serotype 15 challenge \[[@r25]\].

In this study, we determined the nucleotide sequence of the gene involved in the capsular polysaccharide synthesis (CPS) of *A. pleuropneumoniae* serotype 15 (*cps15*). The first aim of this study was to obtain the basic molecular knowledge necessary for the development of *A. pleuropneumoniae* serotype 15 diagnostics, such as PCR serotyping tests, which have been developed in other serotypes \[[@r1], [@r4], [@r12], [@r15], [@r17], [@r24], [@r27]\]. The second aim of this study was to obtain a basic molecular knowledge necessary for the development of vaccine, such as a genetically modified capsule-deficient mutant vaccine \[[@r9]\].

*A. pleuropneumoniae* serotype 15 strain HS143 was used to determine the nucleotide sequence of *cps15*. The organisms were cultivated with TSA agar (Difco, Sparks, MD, U.S.A.) supplemented with 5% defibrinated horse blood and 2% fresh yeast extracts at 37°C. In order to determine the nucleotide sequence of the *cps15*, internal region of *cpxD* of *A. pleuropneumoniae* serotype 15 (*cpxD15*) was PCR-amplified from the genomic DNA of serotype 15 strain H143, which was prepared as described previously \[[@r10]\]. PCR primers were designed from data previously deposited in databases (5′-ACY TCA GGC CCT AGC CAT AST GC-3′ and 5′-CAC ACG ATA AAC CGT YGG TAC ATC-3′) \[[@r26]\]. The amplified PCR products were purified and sequenced as described previously \[[@r11]\]. Since *cps* is usually flanked by *cpxD* in *A. pleuropneumoniae*\[[@r16], [@r26]\], an inverse touchdown PCR was then performed to obtain DNAs flanked by *cpxD* with primers invF (5′-GCA GTA GGC GGA ACA ACG GAA AAC ATT-3′) and invR (5′-ATA TCC CGC ACC GCC TAC AGT ACC TAA AAA-3′), which were designed on the basis of the nucleotide sequence of *cpxD* determined in this study. Purified genomic DNA from serotype 15 strain HS143 was digested with restriction enzymes *Eco*RI and *Hind*III, religated with T4 DNA ligase in order to generate circular template DNAs and used for the following inverse touchdown PCR, respectively. The inverse touchdown PCR was performed in a total volume of 50*µl* containing 1 X buffer (Toyobo, Otsu, Japan); 0.2 mM of each dNTP; 0.3 *µ*M of each primer (invF and invR) and the template DNAs described above. The following amplification steps were used: 1 cycle at 94°C for 2 min (preheating); 5 cycles at 98°C for 10 sec and 74°C for 20 min (first step); 5 cycles at 98°C for 10 sec and 72°C for 20 min (second step); 5 cycles at 98°C for 10 sec and 70°C for 20 min (third step); 20 cycles at 98°C for 10 sec and 68°C for 20 min (forth step); 1 cycle at 68°C for 10 min (final step). Amplified DNAs (approximately 8 and 5 kilobase pairs) were purified by the QIA quick PCR amplification kit (Qiagen, Hilden, Germany) and submitted to nucleotide sequence determination with fluorescent dye terminators as described previously \[[@r11]\]. The nucleotide sequence determined has been deposited under accession number AB701753 in DDBJ/EMBL/GenBank.

The nucleotide sequence of the DNA (8,551 bp) comprising *cps15* was determined. Three open reading frames (ORFs) were located between the *cpx15D* and *lysA* genes (the CPS export gene and the diaminopimelate decarboxylase genes, respectively), which are conserved in *A. pleuropneumoniae* and flanked by the *cps* ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Schematic diagram of the DNA region involved in CPS of *A. pleuropneumoniae* serotype 1 (accession numbers (nos.) AF518558 \[[@r2]\] and ADOD00000000 \[[@r26]\]), 4 (accession nos. GU585380 \[unpublished\] and ADOF00000000 \[[@r26]\]) and 12 (accession. nos. AY496881 \[[@r16]\] and ADOL00000000 \[[@r26]\]). Arrows of the same color indicate open reading frames of encoding proteins exhibit amino acid sequence homology.). The ORFs were designated as *cps15ABC* genes ([Fig.1](#fig_001){ref-type="fig"}) and encoded the Cps15A to Cps15C proteins, respectively. At the amino acid level, Cps15A showed considerably high homology to ORF1 of *Actinobacillus suis*\[[@r18]\] as well as did to Cps1A, Cps4A and Cps12A (CPS phosphotransferase) of *A. pleuropneumoniae* serotypes 1, 4 and 12, respectively \[[@r2], [@r16]\] ([Table 1](#tbl_001){ref-type="table"} Table 1.Identity of Cps protein of *Actinobacillus pleuropneumoniae* serotype 15 (Cps15) compared to those of *A. pleuropneumoniae* and other bacterial species). Cps15B showed overall homology to a glycosyl tranferase of *Mannheimia varigena* and to ORF2 of *A. suis*\[[@r18]\] as well as did to Cps1B, Cps4B and Cps12B (glycosyl transferase family protein) of *A. pleuropneumoniae*\[[@r2], [@r16]\] ([Table 1](#tbl_001){ref-type="table"}). Cps15C showed no homology to any proteins of *A. pleuropneumoniae*, whereas it showed homology to a hypothetical protein of *Corynebacterium resistens*\[[@r23]\] and to a protein involved in CPS biosynthesis of *Neisseria meningitidis* serogroup Z \[[@r8], [@r28]\] ([Table 1](#tbl_001){ref-type="table"}). These findings suggested that a horizontal gene transfer of the *cps* gene across the taxonomically and phylogeneticaly unrelated bacterial classes, including Gram-positive bacteria *C. resistens* and *N. meningitidis* belonging to β-Proteobacteria, might have occurred during capsule evolution. The G+C contents of *cps15A*, *cps15B* and *cps15C* were 26.9, 26.8 and 34.2%, respectively ([Table 1](#tbl_001){ref-type="table"}), which is lower than the 41% (overall G+C content of *A. pleuropneumoniae*) \[[@r26]\], indicating that the *cps15ABC* genes might have been acquired by horizontal gene transfer.

Serotype-specific enzymes that are involved in CPS biosynthesis are probably responsible for the dissimilarities among the CPS chemical structures \[[@r26]\]. However, it has been reported that the CPS structures produced by *A. pleuropneumoniae* serotypes 1 to 13 and 15 can be divided into three groups according to the basic differences in their chemical compositions and structures: Group I (serotypes 1, 4, 12 and 15), with CPS composed solely of repeating oligosaccharide units linked by phosphates; Group II (serotypes 5 and 10), with CPS composed of repeating oligosaccharide units; Group III (serotypes 2, 3, 6--9, 11 and 13), with CPS composed of teichoic acid polymers linked by phosphate diesters \[[@r16], [@r21], [@r26]\]. The genetic organization of the *cps* genes provided molecular evidence to support the CPS grouping of *A. pleuropneumoniae* serotypes \[[@r16], [@r26]\]. The present study revealed that *A. pleuropneumoniae* serotype 15 carries a gene for the CPS phosphotransferase (*cps15A*) which may be involved in the chemical linkage of phosphates in the linear CPS backbone \[[@r26]\]. This, in turn, indicates that *A. pleuropneumoniae* serotype 15 belongs to Group I. This study also revealed that the genetic organization of the *cps* genes of *A. pleuropneumoniae* serotype 15 corresponds to the CPS structural classification, as do serotypes 1--13 \[[@r16], [@r21], [@r26]\].

As shown in [Fig. 1](#fig_001){ref-type="fig"}, the genetic organization of the *cps* was essentially common among *A. pleuropneumoniae* serotypes 1, 4, 12 \[[@r16], [@r26]\] and 15 \[this study\]. However, the orientation of the *cps15ABC* gene against *cpxD* and *lysA* genes was different from that of other *A. pleuropneumoniae* serotypes \[[@r16], [@r26]\] ([Fig. 1](#fig_001){ref-type="fig"}). The different orientation between the *cps15ABC* genes and *cps* genes of other serotypes indicated that an inversion might have occurred only in *A. pleuropneumoniae* serotype 15.

In conclusion, the nucleotide sequence of the *cps15* gene has been determined in this study. We believe that the present results will provide the basic molecular knowledge necessary to develop diagnostics and a vaccine for *A. pleuropneumoniae* serotype 15.
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